<DOC>
	<DOCNO>NCT02210780</DOCNO>
	<brief_summary>This 32-week , randomize , double-blind , placebo-controlled , parallel-group study assess immunization response vaccination adult moderate severe atopic dermatitis treat subcutaneous dupilumab .</brief_summary>
	<brief_title>Study Dupilumab ( REGN668/ SAR231893 ) Immune Responses Adults With Atopic Dermatitis ( AD )</brief_title>
	<detailed_description />
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<criteria>Key 1 . Male female adult age 18 64 year Chronic AD ( accord American Academy Dermatology Consensus Criteria , [ Eichenfeld 2004 ] ) present least 3 year screen visit 2 . Patients documented recent history ( within 6 month screen visit ) inadequate response sufficient course outpatient treatment topical AD medication ( ) , topical AD therapy otherwise inadvisable ( e.g. , side effect safety risk ) . 3 . Eczema Area Severity Index ( EASI ) score ≥16 screen visit baseline visit 4 . Investigator 's Global Assessment ( IGA ) score ≥3 ( 04 IGA scale ) screen baseline visit 5 . ≥10 % body surface area ( BSA ) AD involvement screen baseline visit Key 1 . Prior treatment dupilumab ( REGN668/ SAR231893 ) 2 . Patients need &gt; 10 mg daily prednisone ( include equivalent dos steroid ) high dose systemic corticosteroid ( ≥2 mg/kg ) 14 day longer 16 week treatment period study 3 . History GuillainBarre syndrome 4 . History severe allergic reaction either vaccine vaccine component include alum , thimerosal , phenol 5 . Patients severe reaction natural rubber latex product ( package component vaccine contain rubber latex may cause reaction susceptible individual ) 6 . Treatment biologics within 4 month baseline visit 7 . Chronic acute infection require treatment antibiotic , antiviral , antiparasitics , antifungal within 4 week screen visit superficial skin infection within 1 week screen visit The information list intend contain consideration relevant patient 's potential participation clinical trial inclusion/ exclusion criterion list .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>